ZNF223
gene geneOn this page
Summary
ZNF223 (zinc finger protein 223, HGNC:13016) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 223 (Q9UK11). May be involved in transcriptional regulation.
This gene encodes a protein containing a Kruppel-associated box domain and multiple zinc finger domains. The function of this protein has yet to be determined.
Source: NCBI Gene 7766 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_013361
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13016 |
| Approved symbol | ZNF223 |
| Name | zinc finger protein 223 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000178386 |
| Ensembl biotype | protein_coding |
| Entrez | 7766 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000434772, ENST00000585552, ENST00000588518, ENST00000591850, ENST00000593088, ENST00000911408, ENST00000911409, ENST00000911410, ENST00000911411
RefSeq mRNA: 1 — MANE Select: NM_013361
NM_013361
CCDS: CCDS12635
Canonical transcript exons
ENST00000434772 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001636567 | 44066064 | 44067999 |
| ENSE00001703080 | 44052036 | 44052195 |
| ENSE00003552812 | 44055109 | 44055191 |
| ENSE00003635912 | 44060455 | 44060581 |
| ENSE00003662638 | 44060749 | 44060841 |
Expression profiles
Bgee: expression breadth ubiquitous, 186 present calls, max score 83.60.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5260 / max 108.5483, expressed in 1427 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176242 | 3.5260 | 1427 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 83.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.62 | gold quality |
| cortical plate | UBERON:0005343 | 79.05 | gold quality |
| rectum | UBERON:0001052 | 77.69 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 77.32 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.08 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.73 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.63 | gold quality |
| right lung | UBERON:0002167 | 75.32 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.89 | gold quality |
| gall bladder | UBERON:0002110 | 74.88 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.72 | gold quality |
| transverse colon | UBERON:0001157 | 74.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.42 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.41 | gold quality |
| right adrenal gland | UBERON:0001233 | 74.16 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 74.13 | gold quality |
| granulocyte | CL:0000094 | 74.06 | gold quality |
| body of stomach | UBERON:0001161 | 73.77 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.61 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 73.54 | gold quality |
| ventricular zone | UBERON:0003053 | 73.50 | gold quality |
| body of uterus | UBERON:0009853 | 73.47 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.38 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 73.31 | gold quality |
| left uterine tube | UBERON:0001303 | 73.30 | gold quality |
| minor salivary gland | UBERON:0001830 | 73.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 73.20 | gold quality |
| monocyte | CL:0000576 | 73.16 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.10 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.90 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
49 targeting ZNF223, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 223 — Q9UK11 (reviewed: Q9UK11)
All UniProt accessions (4): Q9UK11, K7EPW2, K7EQ32, K7ER65
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_037493* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (29 total): sequence conflict 15, zinc finger region 10, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UK11-F1 | 64.44 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 43 (showing top):
GOZGIT_ESR1_TARGETS_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, DIDO1_TARGET_GENES, SKIL_TARGET_GENES, SNAI1_TARGET_GENES, UBN1_TARGET_GENES, ZNF33A_TARGET_GENES, ZNF766_TARGET_GENES, ZNF8_TARGET_GENES, ZSCAN31_TARGET_GENES, GSE11057_CD4_EFF_MEM_VS_PBMC_UP, MIR3692_5P, MIR3140_5P
GO Biological Process (2): negative regulation of DNA-templated transcription (GO:0045892), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 2 |
| regulation of DNA-templated transcription | 2 |
| negative regulation of RNA biosynthetic process | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
426 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF223 | ANKRD44 | Q8N8A2 | 348 |
| ZNF223 | ASCC2 | Q9H1I8 | 323 |
| ZNF223 | CDYL2 | Q8N8U2 | 306 |
| ZNF223 | DOP1B | Q9Y3R5 | 305 |
| ZNF223 | TMT1B | Q6UX53 | 273 |
| ZNF223 | GNG13 | Q9P2W3 | 269 |
| ZNF223 | GNG8 | Q9UK08 | 256 |
| ZNF223 | SLC4A5 | Q9BY07 | 252 |
| ZNF223 | GMPR | P36959 | 248 |
| ZNF223 | TRIM4 | Q9C037 | 235 |
| ZNF223 | RFX2 | P48378 | 224 |
| ZNF223 | MEX3C | Q5U5Q3 | 223 |
| ZNF223 | MKRN1 | Q9UHC7 | 222 |
| ZNF223 | GNGT2 | O14610 | 220 |
| ZNF223 | CLN8 | Q9UBY8 | 217 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF223 | MDFI | psi-mi:“MI:0915”(physical association) | 0.780 |
| MDFI | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRTAP10-7 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF223 | ZC4H2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF223 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZC4H2 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CARD10 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCNDBP1 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CABP5 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF223 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF223 | PPM1G | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF223 | CENPB | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF223 | FTH1 | psi-mi:“MI:0914”(association) | 0.350 |
| NDEL1 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF223 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF223 | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF223 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| ZNF223 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CABP5 | ZNF223 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (48): ZNF223 (Two-hybrid), ZC4H2 (Two-hybrid), KRTAP10-7 (Two-hybrid), ZNF223 (Two-hybrid), TRIM39 (Affinity Capture-MS), CENPB (Affinity Capture-MS), TRIM41 (Affinity Capture-MS), ZNF430 (Affinity Capture-MS), ZNF284 (Affinity Capture-MS), ZNF92 (Affinity Capture-MS), TRIM26 (Affinity Capture-MS), EHMT2 (Affinity Capture-MS), STRN4 (Affinity Capture-MS), HAUS4 (Affinity Capture-MS), ZNF714 (Affinity Capture-MS)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 72 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1190 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:44052665:T:A | acceptor_gain | 1.0000 |
| 19:44060743:TTACA:T | acceptor_loss | 1.0000 |
| 19:44060744:TACA:T | acceptor_loss | 1.0000 |
| 19:44060744:TACAG:T | acceptor_loss | 1.0000 |
| 19:44060746:CA:C | acceptor_loss | 1.0000 |
| 19:44060747:A:AG | acceptor_gain | 1.0000 |
| 19:44060747:A:AT | acceptor_loss | 1.0000 |
| 19:44060748:G:GG | acceptor_gain | 1.0000 |
| 19:44060748:GGGC:G | acceptor_gain | 1.0000 |
| 19:44052166:G:GT | donor_gain | 0.9900 |
| 19:44052189:TTTAG:T | donor_gain | 0.9900 |
| 19:44052193:GAG:G | donor_gain | 0.9900 |
| 19:44052193:GAGGT:G | donor_loss | 0.9900 |
| 19:44052194:AG:A | donor_loss | 0.9900 |
| 19:44052195:GGTG:G | donor_loss | 0.9900 |
| 19:44052196:G:T | donor_loss | 0.9900 |
| 19:44052197:T:A | donor_loss | 0.9900 |
| 19:44055095:AT:A | acceptor_gain | 0.9900 |
| 19:44055095:ATG:A | acceptor_gain | 0.9900 |
| 19:44055096:T:G | acceptor_gain | 0.9900 |
| 19:44055096:T:TA | acceptor_gain | 0.9900 |
| 19:44055097:G:A | acceptor_gain | 0.9900 |
| 19:44060578:GTGG:G | donor_gain | 0.9900 |
| 19:44060747:AG:A | acceptor_gain | 0.9900 |
| 19:44060748:GG:G | acceptor_gain | 0.9900 |
| 19:44060839:CAG:C | donor_loss | 0.9900 |
| 19:44060839:CAGGT:C | donor_loss | 0.9900 |
| 19:44060840:AG:A | donor_loss | 0.9900 |
| 19:44060840:AGG:A | donor_loss | 0.9900 |
| 19:44060841:GGT:G | donor_loss | 0.9900 |
AlphaMissense
3234 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:44066549:T:C | F241L | 0.992 |
| 19:44066551:C:A | F241L | 0.992 |
| 19:44066551:C:G | F241L | 0.992 |
| 19:44066633:T:C | F269L | 0.990 |
| 19:44066635:C:A | F269L | 0.990 |
| 19:44066635:C:G | F269L | 0.990 |
| 19:44066885:T:C | F353L | 0.990 |
| 19:44066887:C:A | F353L | 0.990 |
| 19:44066887:C:G | F353L | 0.990 |
| 19:44066717:T:C | F297L | 0.989 |
| 19:44066719:C:A | F297L | 0.989 |
| 19:44066719:C:G | F297L | 0.989 |
| 19:44066919:G:C | R364P | 0.989 |
| 19:44066916:A:C | Q363P | 0.987 |
| 19:44067053:T:C | F409L | 0.985 |
| 19:44067055:T:A | F409L | 0.985 |
| 19:44067055:T:G | F409L | 0.985 |
| 19:44066465:T:C | F213L | 0.979 |
| 19:44066467:C:A | F213L | 0.979 |
| 19:44066467:C:G | F213L | 0.979 |
| 19:44066904:T:C | L359P | 0.979 |
| 19:44066912:C:G | H362D | 0.978 |
| 19:44066690:T:C | F288L | 0.977 |
| 19:44066692:C:A | F288L | 0.977 |
| 19:44066692:C:G | F288L | 0.977 |
| 19:44066926:C:A | H366Q | 0.976 |
| 19:44066926:C:G | H366Q | 0.976 |
| 19:44066988:T:C | L387P | 0.976 |
| 19:44066914:T:A | H362Q | 0.975 |
| 19:44066914:T:G | H362Q | 0.975 |
dbSNP variants (sampled 300 via entrez): RS1000182776 (19:44054388 T>C), RS1000386562 (19:44064466 A>G), RS1000676684 (19:44064343 A>G), RS1000687877 (19:44051628 C>T), RS1001011218 (19:44051925 TC>T), RS1001044091 (19:44052181 A>G), RS1001213346 (19:44061106 C>T), RS1001330681 (19:44054271 C>T), RS1001901307 (19:44052696 A>G), RS1002084090 (19:44058816 G>C), RS1002118337 (19:44059189 C>T), RS1002228353 (19:44052632 G>A), RS1002518478 (19:44059057 G>A), RS1002730598 (19:44061632 C>G), RS1002757999 (19:44062364 A>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008887_7 | Systemising | 9.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010221 | systemising measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| bisphenol A | affects expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Cadmium | increases expression, increases abundance | 1 |
| Cisplatin | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Manganese | increases expression, affects cotreatment, increases abundance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phenylmercuric Acetate | decreases expression, affects cotreatment | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW22 | HEK293 eGFP-ZNF223 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.